SFX by Ex Libris Inc.

Title:	New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity
Source:	Journal of Medicinal Chemistry [0022-2623] Turrado, Carlos yr:2012

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	McFadden, Jill M. "Application of a Flexible Synthesis of (5R)-Thiolactomycin To Develop New Inhibitors of Type I Fatty Acid Synthase." Journal of medicinal chemistry 48.4 (2005): 946-961.
description	2.	Jiang, En-Hui o. "Inhibition of Fatty-acid Synthase Suppresses P-AKT and Induces Apoptosis in Bladder Cancer." Urology 80.2 (2012): 4294967295-4294967295.
description	3.	Tennant, Daniel A. "Targeting metabolic transformation for cancer therapy." Nature Reviews. Cancer 10.4 (2010): 267-277.
description	4.	Skvortsova, I. "Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells." Proteomics 8.21 (2008): 4521-33.
description	5.	Orita, H. "Selective inhibition of fatty acid synthase for lung cancer treatment." Clinical cancer research 13.23 (2007): 7139-7145.
description	6.	Alderton,, Gemma K., Gemma K. "Tumour microenvironment: Macrophages lead the way." Nature Reviews. Cancer 10.3 (2010): 162-163.
description	7.	Jones, Suzanne F. "Molecular Pathways: Fatty Acid Synthase." Clinical cancer research 21.24 (2015): 5434-8.
description	8.	Huang, P. "The "HER2-PI3K/Akt-FASN Axis" regulated malignant phenotype of colorectal cancer cells." Lipids (2012): 403-411.
description	9.	Das, S. "Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1." Carcinogenesis 34.3 (2013): 647-57.
description	10.	Wang. "Overexpression of RING box protein-1 (RBX1) associated with poor prognosis of non-Muscle-Invasive bladder transitional cell carcinoma." Journal of surgical oncology (2013).
description	11.	"The role of oct-1 in the regulation of tracheal antimicrobial peptide (TAP) and lingual antimicrobial peptide (LAP) expression in bovine mammary epithelial cells." Immunogenetics 63.11 (2011): 715-725.
description	12.	Zhang, L. "Association of elevated GRP78 expression with increased astrocytoma malignancy via Akt and ERK pathways." Brain research 1371 (2011): 23-31.
description	13.	Lugthart, S. "Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1." Blood 117.1 (2010): 234-241.
description	14.	Wang, W. "Increased fatty acid synthase as a potential therapeutic target in multiple myeloma." Journal of Zhejiang University. Science B 9.6 (2008): 441-447.
description	15.	Lou, W. "Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway." The Prostate 42.3 (2000): 239-242.
description	16.	Skarnes, Stephen P. "ATP-citrate lyase deficiency in the mouse." The Journal of biological chemistry 279.10 (2004): 9557-9564.
description	17.	Little, JL. "Fatty Acid Synthase Activity in Tumor Cells." Lipids in health and disease (2008): 169-.
description	18.	Landree, Gabriele E. "C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism." The Journal of biological chemistry 279.5 (2004): 3817-3827.
description	19.	Shah, J. "Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR." BMC cancer 8.1 (2008): 284-.
description	20.	Orita, H., Coulter, J., Tully, E., Kuhajda, F. P.,, H. "Inhibiting Fatty Acid Synthase for Chemoprevention of Chemically Induced Lung Tumors." Clinical cancer research 14.8: 2458-64.